Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits?

No clinical characteristics, particularly not sputum characteristics, can guide antibiotic prescription in patients with mild to severe COPD exacerbations https://bit.ly/3e1JV8o

Detalles Bibliográficos
Autores principales: van Velzen, Patricia, ter Riet, Gerben, Brinkman, Paul, Sterk, Peter J., Prins, Jan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Original Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248336/
https://www.ncbi.nlm.nih.gov/pubmed/32494571
http://dx.doi.org/10.1183/23120541.00099-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248336/
https://www.ncbi.nlm.nih.gov/pubmed/32494571
http://dx.doi.org/10.1183/23120541.00099-2020

Ejemplares similares